ArticleJournal of affective disorders2026
White matter abnormalities in bipolar II and unipolar depression - Evidence from fixel-based analysis.
Article in Journal of affective disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
10 authors.
Funding
Abstract
backgroundChallenges in correctly identifying bipolar disorder II (BD-II) during depressive states have led to poor clinical outcomes. BD-II-specific diffusion-weighted imaging studies are lacking. This study addresses current knowledge gaps by comparing white matter (WM) integrity in BD-II and unipolar depression (UD) using fixel-based analysis (FBA).
methodPrimary analyses compared fibre density (FD) among 33 individuals with BD-II, 50 with UD, and 51 healthy controls (HC) in 11 a priori tracts. Sensitivity analyses among unmedicated participants examined whether medication status affects the results. Exploratory analyses assessed FD in 61 remaining tracts and other FBA metrics in all tracts, as well as the effects of illness characteristics on FBA correlates.
resultsBD-II showed reduced FD in the left superior longitudinal fasciculus I (SLFI) compared with HC, while no significant alteration was found in UD. Group differences were similar but less pronounced in unmedicated participants. Exploratory analyses showed shared FD reductions in both groups compared to HC and more widespread disruptions in BD-II than UD. In BD-II, illness duration negatively correlated with FD, while the number of lifetime BD-II depressive episodes positively correlated with the combined fibre density and cross-section measure (FDC).
conclusionsOur findings provide robust evidence of fibre-density reductions in BD-II, highlighting the importance of early intervention in BD-II. While exploratory analyses showed shared WM disruptions in both disorders, BD-II displayed more widespread alterations, and WM alterations that were linked to depressive recurrence and overall illness duration. Future studies with independent and larger samples are warranted to validate these results.
Indexed as
Identifiers
42134743What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.